Literature DB >> 2249204

Recovery of morphine from a controlled-release preparation. A source of opioid abuse.

J C Crews1, D D Denson.   

Abstract

MS-Contin (Purdue-Fredrick, Norwalk, CT) is a controlled-release preparation of morphine sulfate that has demonstrated efficacy in the management of chronic cancer pain problems. It has recently come to the attention of the authors that MS-Contin represents a potential source of opioid abuse through the extraction and intravenous injection of the morphine from this preparation. The authors describe a simple aqueous extraction method that was used to quantitatively determine the extent to which morphine could be obtained from MS-Contin tablets.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2249204     DOI: 10.1002/1097-0142(19901215)66:12<2642::aid-cncr2820661229>3.0.co;2-b

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Abuse potential of various opioid medications.

Authors:  D Brookoff
Journal:  J Gen Intern Med       Date:  1993-12       Impact factor: 5.128

2.  The promotion and marketing of oxycontin: commercial triumph, public health tragedy.

Authors:  Art Van Zee
Journal:  Am J Public Health       Date:  2008-09-17       Impact factor: 9.308

Review 3.  Mitigation of IV Abuse Through the Use of Abuse-Deterrent Opioid Formulations: An Overview of Current Technologies.

Authors:  Richard L Rauck
Journal:  Pain Pract       Date:  2019-02-28       Impact factor: 3.183

4.  Aspiration in lethal drug abuse-a consequence of opioid intoxication.

Authors:  Johannes Nicolakis; Günter Gmeiner; Christian Reiter; Monika Heidemarie Seltenhammer
Journal:  Int J Legal Med       Date:  2020-09-14       Impact factor: 2.686

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.